The translational gap for gene therapies in low| and middle|income ...

The translational gap for gene therapies in low- and middle-income ...

Gene therapies are designed to address the root cause of disease. As scientific understanding of disease prevention, diagnosis, ...

The translational gap for gene therapies in low- and middle-income ...

The translational gap for gene therapies in low- and middle-income countries. Sci Transl Med. 2024 May 08; 16(746):eadn1902.

Muin J. Khoury on LinkedIn: The translational gap for gene therapies ...

The substantial investment, ongoing clinical trials, and the commitment of talent underscore the dedication to advancing cell and gene therapy, ...

The translational gap for gene therapies in low- and middle-income ...

Gene therapies will hopefully become safe and effective treatment options for a wide range of genetic and non-genetic diseases.

The translational gap for gene therapies in low- and middle-income ...

Kevin W. Doxzen, Jennifer E. Adair, Yris Maria Fonseca Bazzo, Daima Bukini, Kenneth Cornetta, Varsha Dalal, Renato Luiz Guerino-Cunha, Suradej Hongeng, ...

The translational gap for gene therapies in low- and middle-income ...

Request PDF | The translational gap for gene therapies in low- and middle-income countries | Gene therapies are designed to address the root cause of ...

Maurizio Scarpa on LinkedIn: The translational gap for gene ...

Maurizio Scarpa's Post · The translational gap for gene therapies in low- and middle-income countries · Explore topics · Sign in to view more ...

The translational gap for gene therapies in low- and middle-income ...

The translational gap for gene therapies in low- and middle-income countries. Kevin W. Doxzen, Jennifer E. Adair, Yris Maria Fonseca Bazzo, Daima Bukini ...

Why Translational Research is Key to Unlocking Cell & Gene ...

Moreover, addressing medical mistrust and fostering partnerships in low- and middle-income countries (LMICs) were emphasized as essential steps ...

The translational gap for gene therapies in low- and middle-income ...

As scientific understanding of disease prevention, diagnosis, and treatment improves in tandem with technological innovation, gene therapies ...

The translational gap for gene therapies in low - Altmetric

The translational gap for gene therapies in low- and middle-income countries · Science Translational Medicine, May 2024 · 10.1126/scitranslmed.adn1902 · 38718130.

Vikram Mathews on X: "The translational gap for gene therapies in ...

Local capacity should be prioritized for gene therapies that combat diseases prevalent in low- and middle-income countries. 3:10 AM · May 12, ...

Gene therapy access: Global challenges, opportunities, and views ...

The current cost of licensed gene therapies is a challenge for high-income countries (HICs) and will make widespread availability in low- to middle-income ...

The translational gap for gene therapies in low- and middle-income ...

The translational gap for gene therapies in low- and middle-income countries. Doxzen, K.W.; Adair, J.E.; Bazzo, YMF; Bukini, D.; Cornetta, K.; Dalal, V.; ...

'If you want to go far, go together' | Fred Hutchinson Cancer Center

Holder of the Fleischauer Family Endowed Chair in Gene Therapy Translation ... gene therapies in low- and middle-income countries. It's a virtual ...

Vladislav Sergeev on X: "RT @TAGHIVscience: The translational ...

RT @TAGHIVscience: The translational gap for gene therapies in low- and middle-income countries https://t.co/kBp0hSd3R7 (open access)

A practical approach for adoption of a hub and spoke model for cell ...

In the context of this study, we define gene therapy as the therapeutic delivery of nucleic acid into a patient's cells to treat disease, and ...

Scientific Advancements in Gene Therapies

What is the status of gene therapy in Low- and Middle- ... The translational gap for gene therapies in low- and middle-income countries.

1st Working Group Report for the Global Gene Therapy Initiative ...

The gene and cell therapy field saw its first approved treatments in Europe in 2012 and the United States in 2017 and is projected to be at ...

Advocating for bringing gene therapy to low-income countries

Moreover, clinical trials for these new gene therapies predominantly take place in developed countries and often overlook the most affected ...